Trainers & Connections

Nebraska suspends trainer David Anderson through 2030 after positive tests

A Hall of Fame trainer's albuterol case, needle possession fine and CBD disqualification pushed Nebraska into a sprawling integrity fight. David Anderson was suspended through April 8, 2030.

David Kumar··2 min read
Published
Listen to this article0:00 min
Nebraska suspends trainer David Anderson through 2030 after positive tests
Photo illustration

David Anderson's Nebraska case turned from one medication positive into a broader integrity probe in just a few weeks, then widened again when investigators found a needle and syringe in his assigned tack room at Fonner Park. By the time the Nebraska Racing and Gaming Commission met on June 12, the Hall of Fame trainer was facing an albuterol positive in Goldies Claim, a CBD disqualification for Goldie's Lock and a sanction that the report said would run through April 8, 2030.

The timeline began on February 14, when Goldies Claim won the sixth race at Fonner Park with Anderson listed as trainer of record. Industrial Laboratories later reported albuterol in a urine sample at 1.65 ng/mL on March 5, and on April 8 a split sample sent by Anderson to EQIAS Labs in Lexington, Kentucky confirmed albuterol at 2.25 ng/mL. Goldies Claim was disqualified and purse money was ordered redistributed, turning a win into a costly regulatory loss.

AI-generated illustration
AI-generated illustration

The possession case deepened the stakes on March 6, when investigators searching Anderson's assigned tack room found a needle and syringe. The Nebraska Board of Stewards fined him $1,000 under Nebraska Racing and Gaming Commission Rule 18.009 for possession, and Industrial Laboratories later confirmed albuterol in the contents of that syringe on April 8. In a sport built on medication limits and stable security, that link made the case about more than a single overage.

A second April ruling added another layer. Goldie's Lock was disqualified from a March 22 third-place finish after testing positive for 7-carboxycannabidiol, or CBD, and Anderson was fined $500 under Rule 18.011. The April 9 stewards ruling suspended him for 365 days, through April 8, 2027, and the June 12 commission agenda listed a Hearing - Dave Anderson so the needle case, the albuterol matter and the CBD positive could be considered together.

The consequences landed on a trainer whose resume made the discipline impossible to ignore. Anderson received an owner/trainer license on January 29, 2026, valid through December 31, 2028, and the ruling listed his birth date as April 16, 1955. He had won more than 2,250 races and earned more than $15 million since starting in 1983, was a longtime Nebraska Horsemen's Benevolent and Protective Association board member and stood as the second-winningest trainer at the current Fonner Park meet before the suspension.

The punishment also revived an older Nebraska memory. In 2010, Anderson was suspended for three years after two horses tested positive for oxycodone and oxymorphone, and commissioner Dennis Lee called that the stiffest penalty handed down since he joined the board in 1988. With state commissions still carrying much of the burden for medication enforcement, Nebraska's action showed how quickly a local tack room, a race positive and a syringe can escalate into a much larger test of racing integrity.

This article was produced by Prism’s automated news system from verified source data, official records, and press releases, then run through automated quality and moderation checks before publishing. The system is built and supervised by the people who set the standards it runs under. Read our full AI policy.

Know something we missed? Have a correction or additional information?

Submit a Tip

Never miss a story.

Get Horse Racing updates weekly. The top stories delivered to your inbox.

Free forever · Unsubscribe anytime

Discussion

More Horse Racing News